Immune therapy scores big win against lung cancer in study
CHICAGO (AP) — New research suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of their biggest wins until now in less common forms of the disease.
One study found using one of these drugs — Merck's Keytruda (kee-TROO-dah) — with usual chemotherapy greatly improved survival for people newly diagnosed with the most common type of cancer that had spread beyond the lungs.
That's a first, and it's expected to quickly set a new standard of care for about 70,000 patients each year in the United States.
Trending Health News... read more
- 15:10 The Latest: US identifies remains of 2 Korean War soldiers
- 14:56 Trump to address drugs, nuclear weapons in UN speeches
- 06:53 Political boot camp for women? One Texas university is working on it
- 00:29 North Korea's offer of concessions comes with a catch for US
- 00:29 Trump's tariffs put GOP candidates in a bind in rural areas